Skip to content
Screener

AbCellera Biologics Inc. ABCL Operating Lease Liabilities (Current)

Operating Lease Liabilities (Current) at other companies

Schrodinger logo
SchrodingerSDGR
$16.48M-2.1%
Twist Bioscience Corporation logo
Twist Bioscience CorporationTWST
$10.44M-31.4%
Recursion Pharmaceuticals, Inc. logo
Recursion Pharmaceuticals, Inc.RXRX
$13.25M+12.9%
Ginkgo Bioworks logo
Ginkgo BioworksDNA
$22.79M-20.4%
Absci Corporation logo
Absci CorporationABSI
$2.04M+19.5%
Avalo Therapeutics logo
Avalo TherapeuticsAVTX
$242K-49.8%

Other financials

Income statement

See full
Revenue$4.1M-76.3%
Operating income-$62.8M-26.6%
Net income-$55.4M-59.6%
EPS (diluted)-$0.18-50.0%

Balance sheet

See full
Cash & equivalents$145.1M+23.5%
Total debt$135.6M-4.5%
Total equity$896.0M-11.0%
Total assets$1.3B-6.7%

Cash flow

See full
Operating cash flow-$33.5M-190%
CapEx$2.1M-84.0%
Free cash flow-$37.4M-68.3%

Valuation

See full
Market cap$2.12B+57.4%
Enterprise value$2.11B+53.8%
P/S32×-8.9×

Profitability

See full
Operating margin-340.3%-127pp
Net margin-248.8%-83.6pp
FCF margin-238.9%-90.9pp

Returns & leverage

See full
Return on equity-17.3%+2.1pp
Debt / equity0.2×0.0×
Current ratio12.8×+1.7×

Where this comes from

Reported directly by AbCellera Biologics Inc. in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseLiabilityCurrent.

The source filing: AbCellera Biologics Inc.’s 10-Q, filed August 5, 2026. Open the filing →

Filed
Aug 5, 2026, 4:28 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001703057-26-000046

FAQ

What is AbCellera Biologics Inc.'s operating lease liabilities (current)?
AbCellera Biologics Inc. (ABCL) reported operating lease liabilities (current) of $5.67M in Q2 2026.
How has AbCellera Biologics Inc.'s operating lease liabilities (current) changed year-over-year?
AbCellera Biologics Inc.'s operating lease liabilities (current) increased by 15.8% year-over-year, from $4.9M to $5.67M.
What is the long-term trend for AbCellera Biologics Inc.'s operating lease liabilities (current)?
Over 5 years (2020 to 2025), AbCellera Biologics Inc.'s operating lease liabilities (current) has grown at a 53.8% compound annual growth rate (CAGR), from $675K to $5.82M.
What does operating lease liabilities (current) mean?
The current portion of operating lease obligations due within one year, representing committed future lease payments under ASC 842.

Ask your AI about AbCellera Biologics Inc.'s operating lease liabilities (current).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude